— Know what they know.
Not Investment Advice

AMRS NASDAQ

Amyris, Inc.
1W: +10.5% 1M: -54.9% 3M: -96.4% 1Y: -98.9% 3Y: -98.6% 5Y: -99.5%
$0.05
Last traded 2023-09-13 — delisted
NASDAQ · Basic Materials · Chemicals - Specialty

Balance Sheet Trends

Total Assets
$825M -13.6% ▼
5Y CAGR: +40.3%
Total Liabilities
$1.3B +91.5% ▲
5Y CAGR: +30.0%
Shareholders Equity
-$484M -292.4% ▼
Cash & Investments
$64M -86.7% ▼
5Y CAGR: +2.5%
Total Debt
$982M +120.5% ▲
5Y CAGR: +42.8%
Net Debt
$917M +2490.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$45M$270K$30M$483M$64M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$45M$270K$30M$483M$64M
Net Receivables$32M$29M$51M$48M$98M
Inventory$12M$28M$43M$75M$112M
Other Current Assets$4M$8M$5M$7M$14M
Total Current Assets$113M$74M$147M$639M$306M
Property, Plant & Equip.$20M$55M$53M$113M$273M
Goodwill & Intangibles$0$0$0$171M$196M
Long-Term Investments$0$5M$2M$9M$11M
Other Non-Current Assets$40M$28M$21M$6M$39M
Total Non-Current Assets$60M$87M$76M$315M$519M
Total Assets$173M$161M$223M$954M$825M
— Liabilities —
Accounts Payable$31M$51M$41M$80M$190M
Short-Term Debt$140M$72M$87M$116M$123M
Deferred Revenue$7M$1M$4M$3M$26K
Other Current Liabilities$46M$37M$31M$71M$74M
Total Current Liabilities$225M$161M$163M$270M$387M
Long-Term Debt$70M$217M$195M$329M$858M
Other Non-Current Liab.$8M$23M$23M$69M$47M
Total Non-Current Liabilities$122M$250M$227M$405M$905M
Total Liabilities$347M$411M$390M$675M$1.3B
— Equity —
Common Stock$5M$5M$5M$5M$5M
Retained Earnings-$1.5B-$1.8B-$2.1B-$2.4B-$2.9B
Accumulated OCI-$43M-$44M-$47M-$53M-$64M
Total Stockholders Equity-$175M-$251M-$172M$251M-$484M
Total Liabilities & Equity$173M$161M$223M$954M$825M
— Key Metrics —
Total Debt$210M$289M$282M$445M$982M
Net Debt$165M$289M$252M-$38M$917M
Total Investments$0$5M$2M$9M$11M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms